Elevated cytidine deaminase activity in patients with vasculitis of the small and medium-sized vessels
Stancik, R.; Lukac, J.; Rovensky, J.; Stancikova, M.
Clinical and Experimental Rheumatology 17(6): 750
1999
ISSN/ISBN: 0392-856X PMID: 10609079 Document Number: 508655
Document emailed within 1 workday
Related Documents
Kluft, O. 1981: The medical library in the small and medium-sized hospital Nederlands Tijdschrift Voor Geneeskunde 125(16): 612-616Honma, Y.; Onozuka, Y.; Okabe-Kado, J.; Kasukabe, T.; Hozumi, M. 1991: Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity Cancer Research 51(17): 4535-4538
Bezborodov, A.M.; Reshetilova, T.A.; Golubenko, I.A. 1974: Isolation of intracellular cytidine deaminase from Penicillium sizowi and study of its properties Mikrobiologiia 43(4): 600-605
Gabrielian, N.I.; Dmitriev, A.A.; Savost'ianova, O.A.; Kizhaeva, E.S.; Vlaskina, L.V. 1985: Medium-sized molecules and the degree of endogenous toxemia in intensive care patients Anesteziologiia i Reanimatologiia 1: 36-38
Gijsbers, G.; van Tulder, R. 2011: New Asian Challenges: Missing Linkages in Asian Agricultural Innovation and the Role of Public Research Organisations in Four Small- and Medium-Sized Asian Countries Science Technolgy and Society 16(1): 29-51
Momparler, R.L.; Doré, B.T.; Labiberté, J.; Momparler, L.F. 1993: Interaction of 5-aza-2'-deoxycytidine with amsacrine or 1,25-dihydroxyvitamin D3 on HL-60 myeloid leukemic cells and inhibitors of cytidine deaminase Leukemia 7(Suppl 1): 17-20
Kirch, H.C.; Schröder, J.; Hoppe, H.; Esche, H.; Seeber, S.; Schütte, J. 1998: Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro Experimental Hematology 26(5): 421-425
Friedrich, J.M.; Mertens, P.; Eversheim, W.; Kampker, R. 2002: Der CW-SCM-Ansatz: Eine komponentenbasierte Supply-Chain-Management-Software für kleine und mittlere Unternehmen - The CW-SCM approach: a component-based supply chain management software for small and medium sized enterprises Wirtschaftsinformatik 44(2): 117-130
Friedrich, J.M.; Mertens, P.; Eversheim, W.; Kampker, R. 2002: Der CW-SCM-Ansatz: Eine komponentenbasierte Supply-Chain-Management-Software für kleine und mittlere Unternehmen - The CW-SCM approach: a component-based supply chain management software for small and medium sized enterprises Wirtschaftsinformatik 44(2): 117-130
Hallan, S.; Naustdal, T. 1994: Bacteremia at a medium-sized Norwegian hospital Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(18): 2102-2106
Görlitzer, K.; Lorenz, A. 2004: Medium sized rings from alprenolol and oxprenolol Die Pharmazie 59(10): 763-769
Klasinc, S. 1976: Frequency of carcinoma in a medium-sized country-hospital Zentralblatt für Chirurgie 101(14): 855-862
Orellana, J.; McPherson, A.R. 1984: Xenon-arc photocoagulation of medium-sized malignant melanomas Annals of Ophthalmology 16(5): 412-416
Dall'aglio, P.; Buzio, C.; Cambi, V.; Arisi, L.; Migone, L. 1972: Retention of medium sized molecules in uremic serum Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 9: 409-416
Barkholz, D. 1985: Medium-sized hospitals should start HMOs to get more control of market Modern Healthcare 15(25): 108
Giroud, M.; Beuriat, P.; Vion, P.; Gisselmann, A.; D'Athis, P.; Dusserre, L.; Dumas, R. 1988: Incidence of cerebrovascular accidents in a medium-sized French town Revue d'Epidemiologie et de Sante Publique 36(4-5): 360-368
Wiontzek, H. 1971: Treatment results of acute myocardial infarct in a medium-sized hospital Zeitschrift für Allgemeinmedizin 47(6): 284-286
Lamprecht, P.; Moosig, F.; Gause, A.; Herlyn, K.; Gross, W.L. 2000: Birmingham vasculitis activity score, disease extent index and complement factor C3c reflect disease activity best in hepatitis C virus-associated cryoglobulinemic vasculitis Clinical and Experimental Rheumatology 18(3): 319-325
Hergesell, O.; Andrassy, K.; Nawroth, P. 1996: Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis Thrombosis and Haemostasis 75(6): 892-898
Wee, A.S.; Cooper, W.B.; Chatham, R.K.; Cobb, A.B.; Murphy, T. 2000: The development of a stroke clinical pathway: an experience in a medium-sized community hospital Journal of the Mississippi State Medical Association 41(7): 648-653